IMTX
Immatics N.V.
NASDAQ · Healthcare · Biotechnology · DE
$9.56
+1.06%Margins
Gross margin
100.0%
EBITDA margin
-464.8%
EBIT margin
-543.8%
Net margin
-495.3%
FCF margin
-503.4%
-51.7%
Return on equity
-42.5%
Return on assets
-54.8%
Return on invested capital
0.08x
Asset turnover
-$239.8M
Cash from operations
$3.05
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026